Cargando…
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.
The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein whose expression is important in the regulation of breast cancer cell growth. The relationship between EGFR status (determined by an immunocytochemical assay) and various prognostic factors was investigated in 164 primary br...
Autores principales: | Gasparini, G., Bevilacqua, P., Pozza, F., Meli, S., Boracchi, P., Marubini, E., Sainsbury, J. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978004/ https://www.ncbi.nlm.nih.gov/pubmed/1419645 |
Ejemplares similares
-
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen
por: Coradini, D, et al.
Publicado: (2003) -
Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989) -
Epidermal growth factor receptor status of histological sub-types of breast cancer.
por: Sainsbury, J. R., et al.
Publicado: (1988) -
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.
por: Nicholson, S., et al.
Publicado: (1988) -
Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)